Endorphin deficiency syndrome (EDS) is a condition where low levels of natural opioids in the brain contribute to addictive behaviors. Endorphins play a vital role in regulating pain, stress, and mood. When deficient, individuals may turn to substances like alcohol or opioids to compensate, leading to dependency. This biological predisposition highlights the neurochemical foundation of addiction. Treatments often involve therapies that stimulate endorphin production, such as exercise, acupuncture, and certain antidepressants. Recognizing EDS in addiction patients is crucial for developing tailored interventions that address this underlying imbalance, improving treatment outcomes and reducing the likelihood of relapse.
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Gangstalking is real, should be studied
Sam Vaknin, Southern Federal University, United Kingdom
Title : Decoding aggression, violence, and substance use in adolescents with conduct disorders: Neurochemical pathways and interventions
Ann Marie Leonard Zabel, Curry College, United States
Title : Sensoria driven genetic decoupling and impaired areal integration in diseases of agency
Denis Larrivee, University of Navarra, Spain
Title : Positive outcome of adherence to the reward deficiency syndrome solution system treatment plan: A longitudinal study
Elizabeth Dale Gilley, The Elle Foundation, United States